Sandisk stock price slips after hours as Morgan Stanley lifts SNDK target to $483, Cantor to $550
27 January 2026
1 min read

Sandisk stock price slips after hours as Morgan Stanley lifts SNDK target to $483, Cantor to $550

New York, January 26, 2026, 17:42 EST — After-hours

  • SNDK slipped 0.6% and fell further in after-hours trading
  • Morgan Stanley and Cantor Fitzgerald bumped up their price targets ahead of the earnings release
  • Options markets reflect expectations of a sharp move following earnings

Sandisk Corp shares dipped on Monday and slid further in after-hours trading, despite Morgan Stanley and Cantor Fitzgerald pushing up their price targets on the flash-memory producer ahead of this week’s earnings. The stock finished the day down 0.6% at $470.80 and dropped another 0.6% to $467.89 in extended trading, after fluctuating between $454.33 and $494.70 during the session. 1

Sandisk’s upcoming results will offer a new glimpse into NAND flash—the memory chips powering solid-state drives and other storage—after a rollercoaster in pricing. The company is set to host its fiscal second-quarter earnings call on Thursday, Jan. 29, at 1:30 p.m. Pacific. 2

Options trading is signaling a warning. GuruFocus noted that options pricing suggests a 50% probability the stock will swing more than 13.87% — roughly $65.59 — after the earnings report. 3

Morgan Stanley’s Joseph Moore bumped his price target to $483 from $273, maintaining an Overweight rating—indicating he expects the stock to beat its peers. He highlighted “exceptional” NAND fundamentals, driven by a spike in enterprise solid-state drives that’s also squeezing consumer markets, according to TipRanks. 4

Sandisk spun off from Western Digital last year and started trading independently on Nasdaq under the ticker SNDK, the company announced at the time. It offers storage products based on NAND flash technology, serving both consumer and enterprise sectors. 5

Tradr ETFs plans to roll out a 2x leveraged Sandisk ETF on Cboe this Tuesday, joining similar offerings linked to Lumentum and Western Digital. Since leveraged ETFs reset daily, they can exaggerate price swings when the underlying stocks are volatile. 6

Sandisk operates in a fiercely competitive space, alongside memory-focused rivals like Micron and storage giants Western Digital and Seagate. The dynamic is straightforward: enterprise demand remains solid, yet consumer electronics can shift gears abruptly.

The risk lies in pricing momentum losing steam or volumes falling short. NAND is inherently cyclical, and any sign of new supply, cautious buyers, or squeezed margins could quickly unravel a crowded trade.

Thursday brings the latest results and outlook. Traders will focus on management’s take on pricing, unit volumes, and margins for the March quarter — and whether their tone aligns with the sharp target hikes seen this morning.

Stock Market Today

Applied Digital stock jumps 25% as AI data-center names rebound — what’s next for APLD

Applied Digital stock jumps 25% as AI data-center names rebound — what’s next for APLD

7 February 2026
Applied Digital Corporation shares jumped 25.52% Friday to $34.95, then slipped to $34.60 after hours. The company reported fiscal Q2 revenue up 250% to $126.6 million and signed leases for 600 MW of data center capacity in North Dakota. Applied Digital broke ground on a new 430‑MW campus in the southern U.S. in January. Financing includes a $100 million promissory note with 8% interest, paid in kind.
Eli Lilly stock pops as FDA targets cheap weight-loss copycats — what to know before Monday

Eli Lilly stock pops as FDA targets cheap weight-loss copycats — what to know before Monday

7 February 2026
Eli Lilly shares rose 3.7% to $1,058.18 Friday after the FDA said it would act against telehealth firm Hims & Hers for marketing a $49 compounded weight-loss pill. The move followed a sharp selloff Thursday when Hims announced plans to sell a version of Novo Nordisk’s Wegovy. Investors remain uncertain how aggressively regulators will police copycat drugs and pricing in the obesity drug market.
Amazon stock slips after $309 million returns settlement; AMZN target raised ahead of earnings
Previous Story

Amazon stock slips after $309 million returns settlement; AMZN target raised ahead of earnings

Intel stock slides again after weak outlook — what comes next for INTC?
Next Story

Intel stock slides again after weak outlook — what comes next for INTC?

Go toTop